Lupin 2024

Stefan Cross

Mayne Pharma closes $625 million generics buy

Mayne Pharma closes $625 million generics buy

GREENVILLE, N.C. — Mayne Pharma has completed its purchase of a package of generic drug products from Teva Pharmaceutical Industries Ltd. and Allergan plc. Mayne said Wednesday that under the $652 million deal, announced in late June, it takes ownership of 37 approved and five filed generic pharmaceutical products. The transaction was the largest generics

Centrum 7/6  banner